Rexinoids as Therapeutics for Alzheimer’s Disease: Role of APOE
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
Current topics in medicinal chemistry - 17(2017), 6, Seite 708-720 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Koster, Kevin [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: |
|---|
| doi: |
10.2174/1568026616666160617090227 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1978567618 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1978567618 | ||
| 003 | DE-627 | ||
| 005 | 20230508062133.0 | ||
| 007 | tu | ||
| 008 | 160719s2017 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1568026616666160617090227 |2 doi | |
| 028 | 5 | 2 | |a PQ20170206 |
| 035 | |a (DE-627)OLC1978567618 | ||
| 035 | |a (DE-599)GBVOLC1978567618 | ||
| 035 | |a (PRQ)crossref_primary_10_2174_15680266166661606170902270 | ||
| 035 | |a (KEY)0446467220170000017000600708rexinoidsastherapeuticsforalzheimersdiseaseroleofa | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 540 |q DNB |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Koster, Kevin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Rexinoids as Therapeutics for Alzheimer’s Disease: Role of APOE |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Smith, Conor |4 oth | |
| 700 | 1 | |a Valencia-Olvera, Ana |4 oth | |
| 700 | 1 | |a Thatcher, Gregory |4 oth | |
| 700 | 1 | |a Tai, Leon |4 oth | |
| 700 | 1 | |a LaDu, Mary |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Current topics in medicinal chemistry |d Hilversum [u.a.] : Bentham Science Publ., 2001 |g 17(2017), 6, Seite 708-720 |w (DE-627)338770283 |w (DE-600)2064823-6 |w (DE-576)435515160 |x 1568-0266 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2017 |g number:6 |g pages:708-720 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.2174/1568026616666160617090227 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 17 |j 2017 |e 6 |h 708-720 | ||